It is well-known that men with a family history of prostate cancer run an increased risk of developing the disease.
The risk for brothers of men with prostate cancer is doubled. But a doubled risk of what, exactly? Prostate cancer may be an indolent condition that does not require treatment, or aggressive and fatal. Obviously, it makes a big difference whether a man has an increased risk of developing the indolent or the aggressive form, but until now these different risks have not been known.
Swedish researchers studied the risk of cancer in over 50,000 brothers of men with prostate cancer. Thirty per cent of the men that had one brother only with prostate cancer were diagnosed with prostate cancer by age 75 years, about double the Swedish national average risk of 13 per cent. Their risk of aggressive prostate cancer was much lower: 9 per cent (national average risk 5 per cent).
In men that had both a father and a brother with prostate cancer, the risk of any form of prostate cancer was as high as 48 per cent; the risk of the aggressive form was 14 per cent.
The researchers also studied how the different risks were affected by the severity of the cancer in an affected brother or father:
“We expected that the risk of aggressive prostate cancer would not be much increased in brothers of men with the indolent form, but it turned out to almost as high as the risk among men with aggressive prostate cancer in the family,” says Associate Professor Ola Bratt at Lund University, who lead the research project.
“This is an important finding that needs to be disseminated to the general public and to healthcare professionals. Men whose father or brother have an indolent, untreated prostate cancer are probably not aware that this increases their own risk of developing aggressive prostate cancer. They might not even know that there is prostate cancer in the family,” says Ola Bratt.
Paper: Ola Bratt, Linda Drevin, Olof Akre, Hans Garmo & Pär Stattin. Family History and Probability of Prostate Cancer, Differentiated by Risk Category – a Nationwide Population-Based Study. Journal of the National Cancer Institute, Volume 108 Issue 10 October 2016 DOI:10.1093/jnci/djw110
Source: Lund University